Theranostic Biomarkers for Schizophrenia
Schizophrenia is a highly heritable, chronic, severe, disabling neurodevelopmental brain disorder with a heterogeneous genetic and neurobiological background, which is still poorly understood. To allow better diagnostic procedures and therapeutic strategies in schizophrenia patients, use of easy acc...
Main Authors: | Matea Nikolac Perkovic, Gordana Nedic Erjavec, Dubravka Svob Strac, Suzana Uzun, Oliver Kozumplik, Nela Pivac |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/4/733 |
Similar Items
-
Association between reduced brain-derived neurotrophic factor concentration & coronary heart disease
by: Aleksandra Sustar, et al.
Published: (2019-01-01) -
The future of Extracellular Vesicles as Theranostics – an ISEV meeting report
by: Carolina Soekmadji, et al.
Published: (2020-01-01) -
Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
by: Matea Nikolac Perkovic, et al.
Published: (2020-06-01) -
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
by: Gloria Bertoli, et al.
Published: (2016-03-01) -
The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology
by: Mark P. S. Dunphy, et al.
Published: (2020-09-01)